Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cell Death and Differentiation

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cdd.4401132PMID 12700649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of drug-induced apoptosis by flow cytometry after alkaline extraction of ethanol fixed cells

  2008cited by this paper
• Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

  2001cited by this paper
• The chemotherapeutic drug 5-fluorouracil induces apoptosis in mouse thymocytes in vivo via activation of the CD95(APO-1/Fas) system.

  2001cited by this paper
• p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.

  2000cited by this paper
• Human and Mouse Fas (APO-1/CD95) Death Receptor Genes Each Contain a p53-responsive Element That Is Activated by p53 Mutants Unable to Induce Apoptosis*

  2000cited by this paper
• Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.

  2000cited by this paper
• Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

  2000cited by this paper
• Methylation of selected CpGs in the human O6‐methylguanine‐DNA methyltransferase promoter region as a marker of gene silencing

  1999cited by this paper
• A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.

  1999cited by this paper
• Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma

  1999cited by this paper
• Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells

  1998cited by this paper
• Thymineless death in colon carcinoma cells is mediated via fas signaling.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

  1996cited by this paper
• Structure of the human APO‐1 gene

  1994influential reference
• A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry.

  1994cited by this paper
• Expression of APO‐1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium

  1994cited by this paper
• Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

  1993cited by this paper
• Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

  1993cited by this paper
• Allelotype of colorectal carcinomas.

  1989cited by this paper

• Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies

  2025cites this paper
• Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases

  2025cites this paper
• Molecular mechanisms in regulation of autophagy and apoptosis in view of epigenetic regulation of genes and involvement of liquid-liquid phase separation.

  2024cites this paper
• The Role of FAS Receptor Methylation in Osteosarcoma Metastasis

  2023cites this paper
• Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

  2023cites this paper
• Exhaustion of CD8+ central memory responder T cell differentiation provokes non-melanoma skin cancer in elderly kidney transplant recipients

  2023cites this paper
• Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo

  2022cites this paper
• Apoptosis evasion via long non-coding RNAs in colorectal cancer

  2022cites this paper
• Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth In Vivo.

  2022cites this paper
• Epigenetic Deregulation of Apoptosis in Cancers

  2021cites this paper
• Drug resistance in colorectal cancer: An epigenetic overview.

  2021cites this paper
• Mechanism of interaction between autophagy and apoptosis in cancer

  2021cites this paper
• The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.

  2020cites this paper
• Anti-cancer effect of toosendanin and its underlying mechanisms

  2019cites this paper
• Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia

  2019cites this paper
• Epigenetic Changes of the Immune System with Role in Tumor Development.

  2018cites this paper
• Regulation of Apoptotic and Necroptotic Cell Death in Skin Cancer

  2018cites this paper
• CD30-REDIRECTED CHIMERIC ANTIGEN RECEPTOR T CELLS TARGET EMBRYONAL CARCINOMA VIA ANTIGEN-DEPENDENT AND FAS/FASL INTERACTIONS

  2018cites this paper
• Regulation of neuronal survival by DNA methyltransferases

  2017cites this paper
• Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update

  2017cites this paper
• The Janus Face of Death Receptor Signaling during Tumor Immunoediting

  2016cites this paper
• Promoter hypermethylation and downregulation of the FAS gene may be involved in colorectal carcinogenesis.

  2016influential citation
• Targeting Programmed Cell Death Using Small‐Molecule Compounds to Improve Potential Cancer Therapy

  2016cites this paper
• Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack

  2015cites this paper
• H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance

  2015cites this paper
• Priming neuroblastoma for cisplatin and etoposide drug therapy

  2015cites this paper
• ChemoresistanceImmune Escape and 5-Fluorouracil Expression To Confer Colon Carcinoma H3K9 Trimethylation Silences Fas

  2015cites this paper
• TNFα sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-induced cell death by NF-κB-mediated expression of Fas

  2015cites this paper
• Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.

  2014cites this paper
• Down-Regulation of BAX Gene During Carcinogenesis and Acquisition of Resistance to 5-FU in Colorectal Cancer

  2014cites this paper
• Analysis of methylation and mRNA expression status ofFADD andFAS genes in patients with oral squamous cell carcinoma

  2014cites this paper
• DNA Methylation and Apoptosis Resistance in Cancer Cells

  2013cites this paper
• Epigonal Conditioned Media from Bonnethead Shark, Sphyrna tiburo, Induces Apoptosis in a T-Cell Leukemia Cell Line, Jurkat E6-1

  2013cites this paper
• Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells

  2013cites this paper
• A CONVENIENT METHOD TO GENERATE METHYLATED AND UN-METHYLATED CONTROL DNA IN METHYLATION STUDIES

  2013cites this paper
• Defective Apoptosis Signaling in Cancer

  2013cites this paper
• Harnessing Death Receptor Signaling for Cancer Treatment

  2013cites this paper
• Diallyl disulfide, from garlic oil, synthesizes human colonic adenocarcinoma cell line (Caco-2) to TNF-alpha- mediated apoptosis through up-regulation of membrane FAS levels

  2013influential citation
• DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells

  2012cites this paper
• Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

  2012cites this paper
• Regulation of cell death in cancer—possible implications for immunotherapy

  2012influential citation
• Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML

  2012cites this paper
• synergism with FAS-ligand demethylation and FAS re-expression, and FAS- mast cells: role of 5-azacytidine and decitabine exert proapoptotic effects on neoplastic

  2012cites this paper
• Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death.

  2012influential citation
• Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models

  2012cites this paper
• 5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.

  2012cites this paper
• Decitabine and Vorinostat Cooperate To Sensitize Colon Carcinoma Cells to Fas Ligand-Induced Apoptosis In Vitro and Tumor Suppression In Vivo

  2012cites this paper
• Targeting Apoptosis Signaling Pathways for Anticancer Therapy

  2011cites this paper
• Functional aspects of cytidine-guanosine dinucleotides and their locations in genes

  2011cites this paper
• Let-7/miR-98 regulate Fas and Fas-mediated apoptosis

  2011cites this paper
• Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer.

  2011cites this paper
• In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer

  2011cites this paper
• Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2

  2011cites this paper
• Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation.

  2010influential citation
• Epigenetic causes of apoptosis resistance in cutaneous T-cell lymphomas.

  2010cites this paper
• Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.

  2010cites this paper
• Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway.

  2010cites this paper
• Epigenetic regulation of cell life and death decisions and deregulation in cancer.

  2010cites this paper
• Evasion of Apoptosis as a Cellular Stress Response in Cancer

  2010cites this paper
• Downregulation of Fas Gene Expression in Sezary Syndrome Is Associated with Promoter

  2010cites this paper
• Mitochondrial Control of Apoptosis and Cancer

  2010cites this paper
• Cell Death and Survival Signaling in Oncogenesis

  2010cites this paper
• Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer

  2010cites this paper
• Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation.

  2009influential citation
• Reduced FAS transcription in clones of U937 cells that have acquired resistance to Fas‐induced apoptosis

  2009cites this paper
• Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer

  2009cites this paper
• IDENTIFICATION OF A METHYLATION HOTSPOT IN THE DEATH RECEPTOR FAS IN BLADDER CANCER

  2009cites this paper
• Tumor resistance to apoptosis

  2009cites this paper
• Apoptosis in Cancer Biology and Cancer Therapeutics

  2009cites this paper
• Regulation of apoptosis during treatment and resistance development in tumour cells

  2008cites this paper
• Targeting cell death in tumors by activating caspases.

  2008cites this paper
• DNA methylation‐mediated nucleosome dynamics and oncogenic Ras signaling

  2008cites this paper
• Dissecting lipid raft facilitated cell signaling pathways in cancer.

  2008cites this paper
• Signal-dependent regulation of gene expression as a target for cancer treatment: inhibiting p38alpha in colorectal tumors.

  2008cites this paper
• Modulation of tumor associated macrophages in solid tumors.

  2008cites this paper
• Targeting apoptosis resistance in rhabdomyosarcoma.

  2008cites this paper
• DNA Methylation Represses IFN-γ–Induced and Signal Transducer and Activator of Transcription 1–Mediated IFN Regulatory Factor 8 Activation in Colon Carcinoma Cells

  2008cites this paper
• 5-Aza-2′-Deoxycytidine Delays Androgen-Independent Disease and Improves Survival in the Transgenic Adenocarcinoma of the Mouse Prostate Mouse Model of Prostate Cancer

  2007cites this paper
• Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.

  2007cites this paper
• Effect of Combined Therapy With Low-Dose 5-Aza-2′-Deoxycytidine and Irinotecan on Colon Cancer Cell Line HCT-15

  2007cites this paper
• Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects

  2007cites this paper
• Progress in studies on the Fas/ FasL expression system and colon carcinoma

  2007cites this paper
• GENE EXPRESSIONS IN HUMAN PROSTATE LNCAP XENOGRAFTS: EFFECTS OF ALPHA- TOCOPHERYL SUCCINATE ( -TOS) AND DIETARY SOYBEAN OIL

  2007cites this paper
• sFAS/sFASL and sMMP-7: New soluble markers of prognosis and response to therapy in advanced colorectal cancer

  2007cites this paper
• The ability of versican to simultaneously cause apoptotic resistance and sensitivity.

  2007cites this paper
• Factor-1 Pathway Macrophages by Up-regulating the Colony-Stimulating Promoting Response in − Mediates the Tumor Growth α Derived Tumor Necrosis Factor-− Colon Cancer Cell

  2007cites this paper
• Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells.

  2006cites this paper
• Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer

  2006cites this paper
• DNA methylation in normal colorectal in hyperplastic polyposis

  2006cites this paper
• DNA methylation and apoptosis.

  2006cites this paper
• The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway.

  2006cites this paper
• Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

  2006cites this paper
• Targeting death receptors in bladder, prostate and renal cancer.

  2006cites this paper
• Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis

  2006cites this paper
• Targeting the Fas/Fas ligand pathway in cancer

  2005cites this paper
• Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

  2004cites this paper
• Association of Epigenetic Inactivation of RASSF1A with Poor Outcome in Human Neuroblastoma

  2004cites this paper
• Exploiting death receptor signaling pathways for tumor therapy.

  2004cites this paper
• Targeting apoptosis pathways in cancer therapy.

  2004cites this paper
• Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

  2004cites this paper